Taberna, M., Torres, M., Alejo, M., Mena, M., Tous, S., Marquez, S., . . . Bravo, I. (2018). The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients.
Citación estilo ChicagoTaberna, M., et al. The Use of HPV16-E5, EGFR, and PEGFR As Prognostic Biomarkers for Oropharyngeal Cancer Patients. 2018.
Cita MLATaberna, M., et al. The Use of HPV16-E5, EGFR, and PEGFR As Prognostic Biomarkers for Oropharyngeal Cancer Patients. 2018.
Precaución: Estas citas no son 100% exactas.